Conference Proceedings
Efficacy and Safety of Alemtuzumab in Treatment-Naive Patients with Relapsing-Remitting MS: Four-Year Follow-up of the CARE-MS I Study
RAL Macdonell, AJ Coles, DL Arnold, H-P Hartung, E Havrdova, KW Selmaj, DH Margolin, J Palmer, P Oyuela, MA Panzara, DAS Compston
MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2015